Chongkundang jointly to develop DDS oral antibiotics.

Published: 2002-10-31 06:57:00

Updated: 2002-10-31 06:57:00

Chongkundang announced to ink an agreement with Dasan Medichem, a drug dosage form research specialized venture company, on Oct. 24 for the joint development of an oral DDS antibiotic.

Dasan will apply the fine particle coating technology to the antibiotics for masking bad tastes and enhancing...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK